Diadema Partners »

Unicycive Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $698k 106k 6.58

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Unicycive Therapeutics

Vivo Capital
Millennium Management
Octagon Capital Advisors
Nantahala Capital Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Logos Global Management
Citadel Advisors
Integral Health Asset Management
Geode Capital Management
Morgan Stanley
Jane Street
Marshall Wace
Dauntless Investment Group

View all funds holding Unicycive Therapeutics